Showing 1,721 - 1,740 results of 100,803 for search '(( 50 ((ppm decrease) OR (nn decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.55s Refine Results
  1. 1721
  2. 1722
  3. 1723

    SIRT5 deficiency suppresses mitochondrial ATP production and promotes AMPK activation in response to energy stress by Mengli Zhang (6331172)

    Published 2019
    “…As a result, SIRT5 deficiency decreases mitochondrial ATP production, increases AMP/ATP ratio, and subsequently activates AMP-activated protein kinase (AMPK) in cultured cells and mouse hearts under energy stress conditions. …”
  4. 1724

    Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

    Published 2013
    “…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”
  5. 1725

    Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

    Published 2015
    “…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
  6. 1726
  7. 1727

    The increases and decreases in year-to-year migration. by Bruce A. Desmarais (334821)

    Published 2013
    “…<p>The upper-left and upper-right plots respectively show the largest 5% of decreases and increases from one state to another; the width of the line corresponds to the magnitude of the exodus. …”
  8. 1728
  9. 1729

    Table_1_Effects of Early Changes in Blood Pressure During Intravenous Thrombolysis on the Prognosis of Acute Ischemic Stroke Patients.docx by Zhong-Xiu Wang (9729359)

    Published 2020
    “…Patients with a lower baseline National Institute of Health Stroke Scale (NIHSS) score (8.25 ± 5.57 vs. 13.51 ± 7.42, P < 0.001), a higher Alberta Stroke Program Early CT Score (ASPECTS; 8.65 ± 1.82 vs. 8.13 ± 2.00, P = 0.005), decreased BP during thrombolysis (69.4% vs. 59.8%, P = 0.037), and steady BP (SD < 10 mmHg) were more likely to have a favorable outcome (73.9% vs. 60.6%, P = 0.019). …”
  10. 1730

    Roscovitine decreases transcription of fibrogenic mediators. by Richard A. Steinman (117481)

    Published 2012
    “…<p><b>A</b>. Roscovitine decreases mRNA expression of <i>CTGF</i>, collagen and fibronectin. …”
  11. 1731
  12. 1732
  13. 1733
  14. 1734
  15. 1735
  16. 1736
  17. 1737
  18. 1738
  19. 1739
  20. 1740